-
Booth C, Matukas L, Tomlinson G. Clinical features and short-term outcomes of 144 patients with SARS in Toronto Area[J]. JAMA, 2003, 289(): 2801-2809. doi: 10.1001/jama.289.21.JOC30885
-
Chau T, Lee K, Yao H. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases[J]. Hepatology, 2004, 39(): 302-310. doi: 10.1002/(ISSN)1527-3350
-
Chow K, Hsiao C, Lin T. Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung[J]. Am J Clin Pathol, 2004, 121(): 574-580. doi: 10.1309/C0EDU0RAQBTXBHCE
-
Ding J, Ning Q, Liu M. Fuliminant hepatic failure hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase[J]. J Virol, 1997, 71(): 9223-9230.
-
Ding Y, Wang H, Shen H. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China[J]. J Pathol, 2003, 200(3): 282-289. doi: 10.1002/(ISSN)1096-9896
-
Drosten C, Gunther S, Preiser W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome[J]. N Engl J Med, 2003, 348(20): 1967-1976. doi: 10.1056/NEJMoa030747
-
Fouchier R, Kuiken T, Schutten M. Aetiology: Kochos postulates fulfilled for SARS virus[J]. Nature, 2003, 423(): 240-. doi: 10.1038/423240a
-
Franks T, Chong P, Chui P. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore[J]. Hum Pathol, 2003, 34(): 743-748. doi: 10.1016/S0046-8177(03)00367-8
-
Gillim-Ross L, Taylor J, Scholl D R. Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR[J]. J Clin Microbiol, 2004, 42(7): 3196-3206. doi: 10.1128/JCM.42.7.3196-3206.2004
-
Glass W, Subbarao K, Murphy B. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice[J]. J Immunol, 2004, 173(): 4030-4039. doi: 10.4049/jimmunol.173.6.4030
-
Ksiazek T, Erdman D, Goldsmith C. A novel coronavirus associated with severe acute respiratory syndrome[J]. N Engl J Med, 2003, 348(): 1953-1966. doi: 10.1056/NEJMoa030781
-
Lamontagne L, Jolicoeur P. Mouse hepatitis virus 3-thymic cell interactions correlating with viral pathogenicity[J]. J Immunol, 1991, 146(9): 3152-3159.
-
Lee N, Hui D, Wu A. A major outbreak of severe acute respiratory syndrome in Hong Kong[J]. N Engl J Med, 2003, 348(): 1986-1994. doi: 10.1056/NEJMoa030685
-
Levy G, Liu M, Ding J. Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis[J]. Am J Pathol, 2000, 156(): 1217-1225. doi: 10.1016/S0002-9440(10)64992-9
-
Lin Y, Shen X, Yang R. Identification of an epitope of SARS-coronavirus nucleocapsid protein[J]. Cell Res, 2003, 13(): 141-145. doi: 10.1038/sj.cr.7290158
-
MacPhee P, Dindzans V, Fung L. Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3[J]. Hepatology, 1985, 5(): 649-660. doi: 10.1002/(ISSN)1527-3350
-
Marra M, Jones S, Astell C. The genome sequence of SARS-associated coronavirus[J]. Science, 2003, 300(): 1399-1404. doi: 10.1126/science.1085953
-
Marsden P, Ning Q, Fung L. The fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis[J]. J Clin Invest, 2003, 112(): 58-66. doi: 10.1172/JCI18114
-
McAuliffe J, Vogel L, Roberts A. Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys[J]. Virology, 2004, 330(1): 8-15. doi: 10.1016/j.virol.2004.09.030
-
Ng L, Hibberd M, Ooi E. A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection[J]. BMC Infect Dis, 2004, 4(): 34-. doi: 10.1186/1471-2334-4-34
-
Ning Q L X, Yan WM. 2004. A method to establish a murine model of fulminant viral hepatitis [Patent]. China.
-
Ning Q, Sun Y, Han M. Role of Fgl2 Prothrombinase/ Fibroleukin in Experimental and Human Allograft Rejection[J]. J Immunol, 2005, 174(): 7403-7411. doi: 10.4049/jimmunol.174.11.7403
-
Osterhaus A, Fouchier R, Kuiken T. The aetiology of SARS: Koch's postulates fulfilled[J]. Philos Trans R Soc Lond B Biol Sci, 2004, 359(): 1081-1082. doi: 10.1098/rstb.2004.1489
-
Peiris J, Chu C, Cheng V. Clinical progression and viral load in a community outbreak of coronavirus-asso-ciated SARS pneumonia: a prospective study[J]. Lancet, 2003, 361(): 1767-1772. doi: 10.1016/S0140-6736(03)13412-5
-
Peiris J, Lai S, Poon L. Coronavirus as a possible cause of severe acute respiratory syndrome[J]. Lancet, 2003, 361(): 1319-1325. doi: 10.1016/S0140-6736(03)13077-2
-
Pope M, Rotstein O, Cole E. Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication[J]. J Virol, 1995, 69(): 5252-5260.
-
Roberts A, Vogel L, Guarner J. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters[J]. J Virol, 2005, 79(1): 503-511. doi: 10.1128/JVI.79.1.503-511.2005
-
Rowe T, Gao G, Hogan R. Macaque model for severe acute respiratory syndrome[J]. J Virol, 2004, 78(): 11401-11404. doi: 10.1128/JVI.78.20.11401-11404.2004
-
Snijder E, Bredenbeek P, Dobbe J. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage[J]. J Mol Biol, 2003, 331(): 991-1004. doi: 10.1016/S0022-2836(03)00865-9
-
To K, Tong J, Chan P. Tissue and cellular tropism of the coronavirus associatedwith severe acute respiratory syndrome: an in-situ hybridization of fatal cases[J]. J Pathol, 2004, 202(): 157-163. doi: 10.1002/(ISSN)1096-9896
-
Wu S, Du C, Wan P. The genome comparison of SARS-CoV and other coronaviruses[J]. Hereditas (Beijing), 2003, 25(): 373-382.
-
Yin C, Wang C, Tang Z. Clinical analysis of multiple organ dysfunction syndrome in patients suffering from SARS[J]. Chin Critica1 Care Med, 2004, 16(): 646-650.
-
Zhang J. Severe acute respiratory syndrome and its lesions in digestive system[J]. World J Gastroenterol, 2003, 9(): 1135-1138. doi: 10.3748/wjg.v9.i6.1135
-
Zhao L, Xing H, Xu L. Effect of SARS-associated coronavirus on peripheral blood picture and liver function[J]. Chin Critica1 Care Med, 2004, 16(): 660-663.
-
Zhao P, Cao J, Zhao L. Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine[J]. Virology, 2005, 331(): 128-135. doi: 10.1016/j.virol.2004.10.016